D. McGowan

发表

Prostate-specific antigen after neoadjuvant androgen suppression in prostate cancer patients receiving short-term androgen suppression and external beam radiotherapy: pooled analysis of four NRG Oncology RTOG randomized clinical trials

Hanks, E. Horwitz, T. Pisansky, 2019 .

Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.

Christopher U. Jones, H. Sandler, J. Efstathiou, 2016, European urology.

A retrospective analysis of the cost effectiveness of treatment with Metastron in patients with prostate cancer metastatic to bone.

A. McEwan, A. Porter, J. Macgillivray, 1994, European urology.

Rdiation therapy in the management of localized carcinoma of the prostate. A preliminary report

D. McGowan, 1977, Cancer.

Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group.

W. Sause, G. Hanks, M. Rotman, 1998, International journal of radiation oncology, biology, physics.

Localization of Radioiodinated Estrogenic Stilbenes in Normal and Neoplastic Rat Prostate

B. Lentle, L. Wiebe, R. J. Flanagan, 1982 .

α-Halostilbenes related to diethylstilbestrol

B. Lentle, L. Wiebe, R. J. Flanagan, 1981 .

Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.

J. Crook, K. Gulenchyn, A. McEwan, 1993, International journal of radiation oncology, biology, physics.

Seminoma of the testis: a 22-year experience with radiation therapy.

D. McGowan, B. Willan, 1985, International journal of radiation oncology, biology, physics.

The Usefulness of Gallium-67 Citrate Scanning in Testicular Seminoma

D. McGowan, H. Penney, BARBARA D. WILLAN, 1987, Clinical nuclear medicine.

Radiotherapy and short-term androgen deprivation for localized prostate cancer.

Christopher U. Jones, H. Sandler, M. Amin, 2011, The New England journal of medicine.

Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials.

D. Grignon, H. Sandler, K. Bae, 2011, International journal of radiation oncology, biology, physics.

Validation of the sexual adjustment questionnaire (SAQ) in prostate cancer patients enrolled on radiation therapy oncology group (RTOG) studies 90-20 and 94-08

L. Gaspar, B. Prestidge, G. Hanks, 1998 .

The adverse influence of prior transurethral resection on prognosis in carcinoma of prostate treated by radiation therapy.

D. McGowan, 1980, International journal of radiation oncology, biology, physics.

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.

Christopher U. Jones, J. Torres-Roca, H. Sandler, 2015, International journal of radiation oncology, biology, physics.

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

Christopher U. Jones, H. Sandler, A. Raben, 2017, Advances in radiation oncology.

Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials.

H. Sandler, E. Horwitz, T. Pisansky, 2019, International journal of radiation oncology, biology, physics.

Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31)

W. Sause, G. Hanks, M. Rotman, 1996 .

Short-term Endocrine Therapy Prior to and during Radiation Therapy Improves Overall Survival in Patients with T1b-T2b Adenocarcinoma of the Prostate and PSA ≤ 20: Initial Results of RTOG 94-08

Christopher U. Jones, H. Sandler, M. Amin, 2010 .

Phase II Radiation Therapy Oncology Group Study of Hormonal Cytoreduction with Flutamide and Zoladex in Locally Advanced Carcinoma of the Prostate Treated with Definitive Radiotherapy

C. Perez, J. Krall, M. Pilepich, 1990, American journal of clinical oncology.

Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: outcome results of RTOG 83-07.

P. Rubin, J. Buzydlowski, M. Pilepich, 1995, International journal of radiation oncology, biology, physics.

The value of extended field radiation therapy in carcinoma of the prostate.

D. McGowan, 1981, International journal of radiation oncology, biology, physics.

Technetium-99M polyphosphate bone scanning in carcinoma of the prostate.

B. Lentle, D. Mcgowan, H. Dierich, 1974, British journal of urology.

A retrospective analysis of the cost effectiveness of treatment with Metastron® (89Sr‐chloride) in patients with prostate cancer metastatic to bone

A. McEwan, A. Porter, J. Macgillivray, 1994, Nuclear medicine communications.

Inferior Clinical Outcomes for Patients With Positive Post-Radiation Therapy Prostate Biopsy: Results From Prospective Randomized Trial RTOG 94-08

Christopher U. Jones, J. Bahary, E. Gore, 2013 .